Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yinfeng Xu

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Molecular Cell|January 21, 2015
Deacetylation of nuclear LC3 drives autophagy initiation under starvationRui Huang, Yinfeng Xu, Wei Wan, et al.
Molecular Cell|October 17, 2017
mTORC1 Phosphorylates Acetyltransferase p300 to Regulate Autophagy and LipogenesisWei Wan, Zhiyuan You, Yinfeng Xu, et al.
Nature Communications|November 3, 2024
A cost-effective climate mitigation pathway for China with co-benefits for sustainabilityMeiqian Chen, Lei Gao, Zhaoxia Guo, et al.
Biochemical and Biophysical Research Communications|December 19, 2020
A novel human anti-TIGIT monoclonal antibody with excellent function in eliciting NK cell-mediated antitumor immunityDong Han, Yinfeng Xu, Xinping Zhao, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Molecular Cell|January 21, 2015
Deacetylation of nuclear LC3 drives autophagy initiation under starvationRui Huang, Yinfeng Xu, Wei Wan, et al.
Molecular Cell|October 17, 2017
mTORC1 Phosphorylates Acetyltransferase p300 to Regulate Autophagy and LipogenesisWei Wan, Zhiyuan You, Yinfeng Xu, et al.
Nature Communications|November 3, 2024
A cost-effective climate mitigation pathway for China with co-benefits for sustainabilityMeiqian Chen, Lei Gao, Zhaoxia Guo, et al.
Biochemical and Biophysical Research Communications|December 19, 2020
A novel human anti-TIGIT monoclonal antibody with excellent function in eliciting NK cell-mediated antitumor immunityDong Han, Yinfeng Xu, Xinping Zhao, et al.
Pageof 5